Devices › Introducer, catheter
Device brand name · Introducer catheter
Vizigo: medical device reports filed with FDA
1,560 reports name it, 2021–2026. Manufacturer given most often on reports: Biosense Webster. Product code DYB.
- 1,560
- device reports naming the brand
- 0% of all MAUDE reports · about 289 a year
- 873
- reports, 12 months to August 2026
- 600 in the 12 months before
- 92.1%
- classified as malfunction
- 64.6% across the product code
- 0.4%
- classified as death, as reported
- 7 reports · not verified by FDA
FDA's MAUDE database holds 1,560 reports that name the brand "Vizigo" (introducer catheter), received between February 2021 and August 2026; the manufacturer given most often on reports is Biosense Webster. Spellings of one product vary from report to report.
873 reports arrived in the 12 months to August 2026, up 46% from 600 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (92.1%), injury (7.4%) and death (0.4%); across all introducer, catheter reports (product code DYB) death is recorded in 3.3% and malfunction in 64.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are fluid/blood leak (29.2%), backflow (20.6%) and material separation (18%). The patient problems coded most often are cardiac tamponade, hemorrhage/blood loss/bleeding and air embolism. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 41,190 reports carrying product code DYB. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Fluid/blood leak | 456 | 29.2% | 10.7% |
| Backflow | 322 | 20.6% | 2% |
| Material separation | 281 | 18% | 12.3% |
| Difficult to advance | 129 | 8.3% | 1.9% |
| Device-device incompatibility | 122 | 7.8% | 1.4% |
| Patient device interaction problem | 115 | 7.4% | 2.4% |
| Breakthe device broke | 62 | 4% | 7.5% |
| Material protrusion/extrusion | 58 | 3.7% | 0.3% |
| Detachment of device or device componentpart of the device came off | 39 | 2.5% | 4.5% |
| Manufacturing, packaging or shipping problem | 35 | 2.2% | 0.3% |
| Partial blockage | 29 | 1.9% | 0.3% |
| Contamination /decontamination problem | 26 | 1.7% | 0.6% |
| Coagulation in device or device ingredient | 24 | 1.5% | 0.1% |
| Material integrity problema problem with the device material | 24 | 1.5% | 1% |
| Material deformation | 20 | 1.3% | 3.3% |
| Material too soft/flexible | 17 | 1.1% | 0.1% |
| Material twisted/bent | 17 | 1.1% | 0.8% |
| Failure to advance | 14 | 0.9% | 1.7% |
| Infusion or flow problema problem with flow or infusion | 14 | 0.9% | 0.1% |
| Mechanical problema mechanical problem | 11 | 0.7% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Cardiac tamponade | 35 | 2.2% |
| Hemorrhage/blood loss/bleeding | 25 | 1.6% |
| Air embolism | 18 | 1.2% |
| Cardiac perforation | 13 | 0.8% |
| Pseudoaneurysm | 12 | 0.8% |
| Hematomaa collection of blood under the skin or in tissue | 11 | 0.7% |
| Perforation of vessels | 8 | 0.5% |
| Stroke/cva | 7 | 0.4% |
| Thrombosis/thrombus | 7 | 0.4% |
| Cardiac arrestthe heart stopped | 6 | 0.4% |
| Ischemic heart disease | 6 | 0.4% |
| Fistula | 4 | 0.3% |
| Low blood pressure/ hypotension | 4 | 0.3% |
| Vascular dissection | 4 | 0.3% |
| Painpain, site not specified | 3 | 0.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Vizigo | Product code DYB | All MAUDE reports |
|---|---|---|---|
| Reports | 1,560 | 41,190 | 26,136,888 |
| Share of that pool | — | 3.8% | 0% |
| Classified as death, per 1,000 reports | 4 | 33 | 9 |
| Classified as injury | 7.4% | 31.2% | 36.2% |
| Classified as malfunction | 92.1% | 64.6% | 62.3% |
| Filed by the manufacturer | 98.5% | 93.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DYB
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath Medium | 1,381 | 0 | 0.1% |
| Micra | 7,144 | 524 | 8.4% |
| GORE DrySeal Flex Introducer Sheath | 1,177 | 283 | 5.3% |
| Edwards eSheath+ Introducer Set | 974 | 393 | 3.1% |
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath - Medium | 885 | 19 | 0.2% |
| Swartz Braided Transseptal Guiding Introducer, SL0, 63 cm Length, 8.5 F | 878 | 212 | 1.5% |
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath Small | 870 | 0 | 0% |
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath - Small | 707 | 11 | 0% |
| Glidesheath Slender | 625 | 95 | 0% |
| Flexor Ansel Guiding Sheath | 575 | 26 | 0.5% |
| Edwards eSheath Introducer Set | 1,393 | 15 | 9.7% |
| Flexor Raabe Guiding Sheath | 539 | 30 | 1.1% |
| Fast-Cath Transseptal Guiding Introducer Swartz SL Transseptal Series, SL1 8. | 505 | 26 | 0.8% |
| Edwards Transfemoral Esheath Unknown | 504 | 9 | 44.6% |
| Swartz Braided Transseptal Introducer, SL0, 8.5 F | 479 | 98 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Vizigo reports
How many FDA reports name Vizigo?
1,560 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 873 in the latest 12 months.
What kinds of events are reported?
malfunction (92.1%), injury (7.4%) and death (0.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
fluid/blood leak (29.2%), backflow (20.6%), material separation (18%), difficult to advance (8.3%) and device-device incompatibility (7.8%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (98.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Vizigo was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.